Those are some great numbers, but it all depends on deals, buyouts, milestones, data, etc. I’m a little more conservative myself, but still shorting for $20-$30 per share is more likely by years end, but hey! We can all dream, right? This drug has so much potential, I wouldn’t be surprised by anything.
That's just the definition of growth per APR. We or any stock on the rise cannot sustain that. I was saying 200% in 3 mobths translates to 8000% per year.
IT JUST SHOWS INVESTORS TO CATCH IT NOW IF THE THINK ALL THESE CATALYSTS WILL POP THIS BY EOD OF MARCH.
For instance $1000 in month 0 $3000 in month 3 (which I was projecting this to get the APR) $9000 in month 6 $27000 in month 9 $81000 in month 12
Market Data 
Markets 
AI
